Arthritis, Musculoskeletal and Skin Diseases Research - Training Institutional (TI)
Active
- Assistance listing
- 93.AR4
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Grant awards
- Not on record
Program facts
- Treasury account
-
- 75-0888-0-1-552
- More information
Program details come from SAM.gov Assistance Listings. Updated .
About this program
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) within the National Institutes of Health funds institutional training grants under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.AR4), with no current open grant opportunities identified as of the date of this summary.
The program supports training of basic and clinical scientists through investigator-initiated applications and solicited applications in response to published Requests for Applications (RFAs) or Program Announcements (PAs). NIAMS accepts both research grants and contracts addressing the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases at institutions throughout the United States and internationally.
Applications undergo a two-stage peer review process: initial scientific and technical merit review by panels convened through the NIH Center for Scientific Review, followed by second-level review by the NIAMS National Advisory Council, which evaluates scientific quality, mission relevance, portfolio balance, and public health priorities. The NIAMS Institute Director holds final funding authority based on peer review results, Council recommendations, program priorities, and available appropriations. Following selection for funding, applicants must complete Just-in-Time requirements including verification of human subjects protections, animal use compliance, and other regulatory assurances before the Grants Management Officer issues a Notice of Award.
Recipients must retain financial and programmatic records, supporting documentation, statistical records, and other grant-pertinent materials for three years from the date the annual Financial Status Report is submitted to NIH, with extended retention required if litigation, claims, financial management reviews, or audits are underway. The HHS Inspector General, U.S. Comptroller General, and authorized representatives retain unrestricted right of access to recipient records pertaining to awards for audit and examination purposes.
The source provides no recent grant award data, portfolio concentration figures, award economics, or representative funded projects. No funding opportunity deadline is currently posted.
Objective and description
- Objective
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) mission is to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; training of basic and clinical scientists
- Description
The NIAMS funds research projects at institutions throughout the U.S. and around the world. We accept investigator-initiated applications, as well as accept applications for research grants and contracts in response to a published funding opportunity-Request for Applications (RFA) or Program Announcements (PA) to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases.
How to apply
- Award procedure
Applications are evaluated for scientific and technical merit by peer review panels convened either by the NIH Center for Scientific Review, resulting in written critiques and an overall impact score. Applications then undergo second-level review by the NIAMS National Advisory Council, which advises on scientific quality, relevance to the NIAMS mission, portfolio balance, and public health priorities. Following Council review, final approval authority rests with the NIAMS Institute Director, who makes funding decisions based on peer review results, Council and Institute staff recommendations, program priorities, and the availability of appropriated funds. Once an application is selected for funding, NIAMS staff coordinate with the applicant to complete Just-in-Time requirements, including verification of human subjects, animal use, and other regulatory assurances as applicable. NIAMS Grants Management Officers then review the application for administrative, financial, and policy compliance and are responsible for issuing the Notice of Award (NoA).
- Appeals
From 30 to 60 days. A principal investigator may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. A description of the NIH Peer Review Appeal procedures is available on the NIH home page at grants.nih.gov.
Quick answers
What is Assistance Listing 93.AR4?
Assistance Listing 93.AR4 is Arthritis, Musculoskeletal and Skin Diseases Research - Training Institutional (TI), a federal grant program run by National Institutes of Health (Department of Health and Human Services).
What is the CFDA number for Arthritis, Musculoskeletal and Skin Diseases Research - Training Institutional (TI)?
Its CFDA number is 93.AR4: Assistance Listing numbers were called CFDA numbers before 2018.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program